Undiscovered Gems in the US Market for March 2025

Over the last seven days, the United States market has experienced a 1.9% drop, yet it remains up by 14% over the past year with anticipated earnings growth of 14% per annum in the coming years. In this dynamic environment, identifying stocks that are not only resilient but also positioned for long-term growth can be key to uncovering undiscovered gems in the market.

Top 10 Undiscovered Gems With Strong Fundamentals In The United States

Name	Debt To Equity	Revenue Growth	Earnings Growth	Health Rating
Morris State Bancshares	9.72%	4.93%	6.51%	★★★★★★
Wilson Bank Holding	NA	7.87%	8.22%	★★★★★★
Cashmere Valley Bank	15.51%	5.80%	3.51%	★★★★★★
Omega Flex	NA	0.39%	2.57%	★★★★★★
Teekay	NA	-0.89%	62.53%	★★★★★★
Anbio Biotechnology	NA	8.43%	184.88%	★★★★★★
FRMO	0.08%	38.78%	45.85%	★★★★★☆
Gulf Island Fabrication	20.41%	-7.88%	41.10%	★★★★★☆
Pure Cycle	5.15%	-2.61%	-6.23%	★★★★★☆
Reitar Logtech Holdings	31.39%	231.46%	41.38%	★★★★☆☆

Click here to see the full list of 280 stocks from our US Undiscovered Gems With Strong Fundamentals screener.

Underneath we present a selection of stocks filtered out by our screen.

SIGA Technologies (NasdaqGM:SIGA)

Simply Wall St Value Rating: ★★★★★★

Overview: SIGA Technologies, Inc. is a commercial-stage pharmaceutical company that specializes in health security markets in the United States, with a market cap of $387.73 million.

Operations: SIGA Technologies generates revenue primarily from its pharmaceuticals segment, amounting to $173.73 million. The company's financial performance is highlighted by a significant net profit margin trend worth noting.

SIGA Technologies, a nimble player in the pharmaceuticals sector, has recently turned profitable and is trading at 82.7% below its estimated fair value. With no debt on its books compared to a debt-to-equity ratio of 76.7% five years ago, SIGA showcases financial discipline. The firm boasts high-quality non-cash earnings and positive free cash flow, which are promising indicators of operational efficiency. Recent regulatory approval in Japan for TEPOXX enhances its global footprint, though mixed results from clinical trials highlight potential challenges ahead. These dynamics position SIGA as an intriguing prospect within the industry landscape.

• Click to explore a detailed breakdown of our findings in SIGA Technologies' health report.

• Gain insights into SIGA Technologies' historical performance by reviewing our past performance report.

Legacy Housing (NasdaqGS:LEGH)

Simply Wall St Value Rating: ★★★★★★

Overview: Legacy Housing Corporation focuses on constructing, selling, and financing manufactured homes and tiny houses mainly in the southern United States, with a market capitalization of approximately $591.15 million.

Operations: Legacy Housing Corporation generates revenue primarily from its manufactured buildings segment, amounting to $163.72 million. The company's financial performance includes a focus on gross profit margin trends, which provide insights into its operational efficiency and cost management strategies.

Legacy Housing stands out with its focus on boosting production efficiency and expanding dealer networks, particularly in Texas and the Carolinas. Trading at 13.2% below estimated fair value, it offers potential upside despite recent negative earnings growth of -19.2%. The net debt to equity ratio has impressively decreased from 7.6% to 0.4% over five years, indicating strong financial management. While earnings are forecasted to grow by 8.16% annually, challenges like high-interest rates and production issues could impact stability. Recent board changes might also influence strategic directions as the company navigates these opportunities and risks in the manufactured homes sector.

• Legacy Housing's strategic expansion and efficiency upgrades aim to boost revenue growth. Click here to explore the full narrative on Legacy Housing's potential.

Hovnanian Enterprises (NYSE:HOV)

Simply Wall St Value Rating: ★★★★☆☆

Overview: Hovnanian Enterprises, Inc. is a company that designs, constructs, markets, and sells residential homes in the United States with a market capitalization of approximately $602.45 million.

Operations: Hovnanian Enterprises generates revenue primarily from its homebuilding operations across the West, Northeast, and Southeast regions, with the West contributing $1.48 billion and the Northeast $1.13 billion. The financial services segment adds an additional $75.74 million to its revenue streams.

Hovnanian Enterprises, a notable player in the housing sector, has shown impressive financial strides despite its small cap status. With earnings growth of 23.4% last year outpacing the Consumer Durables industry at 5.7%, it highlights robust performance. The company's price-to-earnings ratio stands attractively low at 2.7x against the US market's 17.5x, suggesting good value for investors seeking opportunities in this space. Recent buybacks saw Hovnanian repurchase over 869,000 shares for $66 million since September 2022, reflecting strategic capital allocation efforts to boost shareholder value amidst a challenging forecasted decline in earnings by an average of 46% annually over three years.

• Get an in-depth perspective on Hovnanian Enterprises' performance by reading our health report here.

• Assess Hovnanian Enterprises' past performance with our detailed historical performance reports.

Make It Happen

• Click this link to deep-dive into the 280 companies within our US Undiscovered Gems With Strong Fundamentals screener.
• Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
• Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.

Seeking Other Investments?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com